Humacyte, Inc.
HUMA
$1.26
-$0.05-3.82%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.58% | 30.82% | -77.65% | -27.05% | 3.42% |
| Total Depreciation and Amortization | -0.22% | 1.85% | -0.67% | -2.29% | 0.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -144.67% | -62.52% | 298.15% | 581.80% | -73.51% |
| Change in Net Operating Assets | -173.26% | -15.87% | 187.08% | -248.83% | -55.59% |
| Cash from Operations | -16.02% | -7.59% | 22.15% | -43.52% | -46.49% |
| Capital Expenditure | 93.25% | -407.61% | 52.94% | -160.67% | 69.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.25% | -407.61% | 52.94% | -160.67% | 69.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.12% | -2.33% | -6.80% | -2.55% | -1.91% |
| Issuance of Common Stock | 10,033.74% | -37.10% | -98.19% | 17,053.36% | 155.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.75% | 266.07% | -103.05% | -- | 100.00% |
| Cash from Financing | 5,907.77% | 281.80% | -100.74% | 18,844.78% | 56.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 205.98% | -4.79% | -162.59% | 279.42% | -36.98% |